UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Randomised phase II study of axitinib or bevacizumab combined with paclitaxel/carboplatin as first-line therapy for patients with advanced non-small-cell lung cancer

Annals of oncology, 2014-01, Vol.25 (1), p.132-138

2014

Volltextzugriff (PDF)

Predicting gene promoter methylation in non-small-cell lung cancer by evaluating sputum and serum

British journal of cancer, 2007-04, Vol.96 (8), p.1278-1283

2007

Volltextzugriff (PDF)

Baseline tumour measurements predict survival in advanced non-small cell lung cancer

British journal of cancer, 2013-09, Vol.109 (6), p.1476-1481

2013

Volltextzugriff (PDF)

Dosing to rash: A phase II trial of the first-line erlotinib for patients with advanced non-small-cell lung cancer an Eastern Cooperative Oncology Group Study (E3503)

European journal of cancer (1990), 2014-01, Vol.50 (2), p.302-308

2014

Volltextzugriff (PDF)

Differential effect of age on survival in advanced NSCLC in women versus men: Analysis of recent Eastern Cooperative Oncology Group (ECOG) studies, with and without bevacizumab

Lung cancer (Amsterdam, Netherlands), 2012-06, Vol.76 (3), p.410-415

2012

Volltextzugriff (PDF)

Topotecan Versus Observation After Cisplatin Plus Etoposide in Extensive-Stage Small-Cell Lung Cancer: E7593—A Phase III Trial of the Eastern Cooperative Oncology Group

Journal of clinical oncology, 2001-04, Vol.19 (8), p.2114-2122

2001

Volltextzugriff (PDF)

Topotecan Versus Cyclophosphamide, Doxorubicin, and Vincristine for the Treatment of Recurrent Small-Cell Lung Cancer

Journal of clinical oncology, 1999-02, Vol.17 (2), p.658-667

1999

Volltextzugriff (PDF)

A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small-cell lung cancer

Annals of oncology, 2015-02, Vol.26 (2), p.354-362

2015

Volltextzugriff (PDF)

Phase II study of topotecan in patients with extensive-stage small-cell carcinoma of the lung: an Eastern Cooperative Oncology Group Trial

Journal of clinical oncology, 1996-08, Vol.14 (8), p.2345-2352

1996

Volltextzugriff (PDF)

Chemical components separation with botulinum toxin A: a novel technique to improve primary fascial closure rates of the open abdomen

Hernia : the journal of hernias and abdominal wall surgery, 2013-02, Vol.17 (1), p.101-107

2013

Volltextzugriff (PDF)

Retrograde jejunogastric intussusception due to suture concretion

Annals of the Royal College of Surgeons of England, 2016-03, Vol.98 (3), p.e45-e46

2016

Volltextzugriff (PDF)

Phase II randomized trial of carboplatin, paclitaxel, bevacizumab with or without cixutumumab (IMC-A12) in patients with advanced non-squamous, non-small-cell lung cancer: a trial of the ECOG-ACRIN Cancer Research Group (E3508)

Annals of oncology, 2017-12, Vol.28 (12), p.3037-3043

2017

Volltextzugriff (PDF)

Potentiation of platinum antitumor effects in human lung tumor xenografts by the angiogenesis inhibitor squalamine : Effects on tumor neovascularization

Clinical cancer research, 1999-12, Vol.5 (12), p.4287-4294

1999

Volltextzugriff (PDF)

Amifostine, cisplatin, and vinblastine in metastatic non-small-cell lung cancer: a report of high response rates and prolonged survival

Journal of clinical oncology, 1996-06, Vol.14 (6), p.1913-1921

1996

Volltextzugriff (PDF)

Randomized trial of vinorelbine compared with fluorouracil plus leucovorin in patients with stage IV non-small-cell lung cancer

Journal of clinical oncology, 1996-10, Vol.14 (10), p.2774-2784

1996

Volltextzugriff (PDF)

The influence of gender on survival and tumor recurrence following adjuvant therapy of completely resected stages II and IIIa non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2002-09, Vol.37 (3), p.303-309

2002

Volltextzugriff (PDF)

Phase I trial of 3-hour infusion of paclitaxel with or without granulocyte colony-stimulating factor in patients with advanced cancer

Journal of clinical oncology, 1994-02, Vol.12 (2), p.241-248

1994

Volltextzugriff (PDF)

Hyperparathyroidism and pregnancy

The American journal of surgery, 1999, Vol.177 (1), p.66-68

1999

Volltextzugriff (PDF)

Effect of amifostine on toxicities associated with sequential chemotherapy and radiation therapy for unresectable non-small-cell lung cancer: results of a phase II trial

Journal of clinical oncology, 1997-08, Vol.15 (8), p.2850-2857

1997

Volltextzugriff (PDF)

Phase IB trial of chimeric antidisialoganglioside antibody plus interleukin 2 for melanoma patients

Clinical cancer research, 1997-08, Vol.3 (8), p.1277-1288

1997

Volltextzugriff (PDF)

Current Standards of Care in Small-Cell and Non-Small-Cell Lung Cancer

Oncology, 2001-01, Vol.61 (Suppl 1), p.3-13

Schiller, Joan H.

2001

Volltextzugriff (PDF)

Eastern cooperative group trial of interferon gamma in metastatic melanoma: an innovative study design

Clinical cancer research, 1996-01, Vol.2 (1), p.29-36

1996

Volltextzugriff (PDF)

Dose-ranging study of recombinant human granulocyte-macrophage colony-stimulating factor in small-cell lung carcinoma

Journal of clinical oncology, 1994-12, Vol.12 (12), p.2667-2676

1994

Volltextzugriff (PDF)

High-dose cisplatin and vinblastine plus amifostine for metastatic non-small cell lung cancer

Seminars in oncology, 1996-08, Vol.23 (4 Suppl 8), p.78

Schiller, J H

1996

Volltextzugriff (PDF)

A Phase I Trial of c-Raf Kinase Antisense Oligonucleotide ISIS 5132 Administered as a Continuous Intravenous Infusion in Patients with Advanced Cancer

Clinical cancer research, 2000-05, Vol.6 (5), p.1626

2000

Volltextzugriff (PDF)

1 – 25 von 360

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(332)
Mit Volltextzugriff
(298)

Publikationsform

Artikel
(360)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(343)
Science & Technology
(312)
Life Sciences & Biomedicine
(303)
Male
(291)
Adult
(220)
Middle Aged
(218)
Aged
(168)
Biological And Medical Sciences
(158)
Medical Sciences
(153)
Oncology
(112)
Adolescent
(82)
Treatment Outcome
(60)
Pharmacology. Drug Treatments
(54)
Lung Neoplasms - Drug Therapy
(51)
Aged, 80 And Over
(49)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(47)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(43)
Child
(42)
Antineoplastic Agents
(41)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Randomised phase II study of axitinib or bevacizumab combined with paclitaxel/carboplatin as first-line therapy for patients with advanced non-small-cell lung cancer

Predicting gene promoter methylation in non-small-cell lung cancer by evaluating sputum and serum

Baseline tumour measurements predict survival in advanced non-small cell lung cancer

Dosing to rash: A phase II trial of the first-line erlotinib for patients with advanced non-small-cell lung cancer an Eastern Cooperative Oncology Group Study (E3503)

Differential effect of age on survival in advanced NSCLC in women versus men: Analysis of recent Eastern Cooperative Oncology Group (ECOG) studies, with and without bevacizumab

Topotecan Versus Observation After Cisplatin Plus Etoposide in Extensive-Stage Small-Cell Lung Cancer: E7593—A Phase III Trial of the Eastern Cooperative Oncology Group

Topotecan Versus Cyclophosphamide, Doxorubicin, and Vincristine for the Treatment of Recurrent Small-Cell Lung Cancer

A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small-cell lung cancer

Phase II study of topotecan in patients with extensive-stage small-cell carcinoma of the lung: an Eastern Cooperative Oncology Group Trial

Chemical components separation with botulinum toxin A: a novel technique to improve primary fascial closure rates of the open abdomen

Retrograde jejunogastric intussusception due to suture concretion

Phase II randomized trial of carboplatin, paclitaxel, bevacizumab with or without cixutumumab (IMC-A12) in patients with advanced non-squamous, non-small-cell lung cancer: a trial of the ECOG-ACRIN Cancer Research Group (E3508)

Potentiation of platinum antitumor effects in human lung tumor xenografts by the angiogenesis inhibitor squalamine : Effects on tumor neovascularization

Amifostine, cisplatin, and vinblastine in metastatic non-small-cell lung cancer: a report of high response rates and prolonged survival

Randomized trial of vinorelbine compared with fluorouracil plus leucovorin in patients with stage IV non-small-cell lung cancer

The influence of gender on survival and tumor recurrence following adjuvant therapy of completely resected stages II and IIIa non-small cell lung cancer

Phase I trial of 3-hour infusion of paclitaxel with or without granulocyte colony-stimulating factor in patients with advanced cancer

Hyperparathyroidism and pregnancy

Effect of amifostine on toxicities associated with sequential chemotherapy and radiation therapy for unresectable non-small-cell lung cancer: results of a phase II trial

Phase IB trial of chimeric antidisialoganglioside antibody plus interleukin 2 for melanoma patients

Current Standards of Care in Small-Cell and Non-Small-Cell Lung Cancer

Eastern cooperative group trial of interferon gamma in metastatic melanoma: an innovative study design

Dose-ranging study of recombinant human granulocyte-macrophage colony-stimulating factor in small-cell lung carcinoma

High-dose cisplatin and vinblastine plus amifostine for metastatic non-small cell lung cancer

A Phase I Trial of c-Raf Kinase Antisense Oligonucleotide ISIS 5132 Administered as a Continuous Intravenous Infusion in Patients with Advanced Cancer

Aktive Filter

Suchergebnisse filtern